CCL18 and COVID-19: C-C motif chemokine 14, C-C motif chemokine 18, and C-X-C motif chemokine ligand 12 were dramatically down-regulated in COVID-19 patients, indicating decreased monocyte activation, B cell migration, and T cell-mediated immune response (Fig. 2a and Supplementary Data 7).